PlantForm Corporation awarded Best Specialty Protein Drug Biopharmaceutical Company 2019

GUELPH, Ont., October 2, 2019PlantForm Corporation has been awarded Best Speciality Protein Drug Biopharmaceutical Company 2019 in Global Health & Pharma’s 2019 Healthcare and Pharmaceutical Awards.

“PlantForm is pleased to be recognized for our exceptionally versatile vivoXPRESS® biopharmaceutical manufacturing platform for speciality antibody drugs, protein drugs and vaccines,” said Dr. Don Stewart, PlantForm President and CEO.

“We are using the vivoXPRESS® platform to develop a wide range of products, from biosimilar programs with partners in Brazil and South Africa to medical countermeasures for biosecurity and other threats through our subsidiary AntoXa Corporation.”

The vivoXPRESS® manufacturing platform is also available for licensing opportunities. It is being used by clients from around the world for a wide range of targets through collaboration and research agreements and programs.

The growing portfolio of countermeasures, for example, includes a best-in-class, highly potent antibody for ricin exposure developed by AntoXa Corporation in partnership with the Government of Canada.

About PlantForm Corporation (
PlantForm Corporation is a biopharmaceutical company focused on the rapid development and production of specialty antibody and protein drugs using the company’s proprietary vivoXPRESS® platform. The plant-based vivoXPRESS® system makes it easier, faster and less expensive to produce approved biologic drugs for novel indications and new markets. The company’s pipeline includes trastuzumab for a novel indication in nerve regeneration, a biosimilar version of Lucentis® and other niche indication drugs. Learn more.                                                     

For more information, please contact:
Don Stewart
President and CEO
+1 416-452-7242
Stacey Curry Gunn
Director of Communications
+1 519-827-1131

For more on vivoXPRESS® licensing opportunities for biopharmaceutical research and development, contact:

David Cayea
Chief Operating Officer, PlantForm Corp.


Join us online!
Get regular updates on our activities and industry news by following PlantForm on Twitter, LinkedIn and Facebook:
                        Facebook page - PlantForm
PlantForm is a Canadian company focused on providing
low-cost therapeutic antibody drugs that fight cancer and other critical illnesses.
Our mailing address is:
1920 Yonge St, Suite 200
Toronto, Ontario
For more information, contact:
Don Stewart
President & CEO
Email Marketing Powered by Mailchimp

This email was sent to
why did I get this?    unsubscribe from this list    update subscription preferences
PlantForm Corporation · 1920 Yonge Street, Suite 200 · Toronto, Ontario M4S 3E2 · Canada

Email Marketing Powered by Mailchimp